SEC Form 4 · accession 0001127602-16-046303
LABCORP HOLDINGS INC. · LH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Deborah L Keller
Officer — CEO, Covance Drug Development
Period of report
Mar 11, 2016
Accepted (ET)
Mar 15, 2016 · 1:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920148
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 11, 2016 | M | 1,220 | — | A | 12,632 | D | |
| Common Stock | Mar 11, 2016 | F | 374 | $115.49 | D | 12,257 | D | |
| Common StockF1 | Mar 11, 2016 | M | 11,710 | — | A | 23,967 | D | |
| Common Stock | Mar 11, 2016 | F | 4,213 | $115.49 | D | 19,754 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF4,F1,F3 | — | Mar 11, 2016 | M | 1,220 | D | — | — | Common Stock | 1,220 | 29,980 | D |
| Restricted Stock UnitF4,F1,F5 | — | Mar 11, 2016 | M | 11,710 | D | — | — | Common Stock | 11,710 | 18,270 | D |
Explanation of responses
- F1Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
- F2Stock withholding to satisfy tax withholding obligations.
- F3The Restricted Stock Units vest in three equal annual installments beginning on 3/11/16.
- F4This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
- F5The Restricted Stock Units vest in two equal annual installments beginning on 3/11/16.